(Q48273852)

10 February 2018

title

Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused. (English)

1 reference

10 February 2018

0 references

1 reference

Haeck IM

1

1 reference

10 February 2018

Timmer-de Mik L

2

1 reference

10 February 2018

Lentjes EG

3

1 reference

10 February 2018

Buskens E

4

1 reference

10 February 2018

Hijnen DJ

5

1 reference

10 February 2018

Guikers C

6

1 reference

10 February 2018

Bruijnzeel-Koomen CA

7

1 reference

10 February 2018

de Bruin-Weller MS

8

1 reference

10 February 2018

language of work or name

English

0 references

publication date

12 February 2007

1 reference

10 February 2018

British Journal of Dermatology

published in

1 reference

10 February 2018

volume

156

1 reference

10 February 2018

issue

5

1 reference

10 February 2018

page(s)

979-985

1 reference

10 February 2018

Percutaneous absorption of hydrocortisone-4-C14 in two human subjects

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07753.X

Adverse effects of topical glucocorticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07753.X

Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07753.X

Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07753.X

Topical corticosteroid-induced adrenocortical insufficiency: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07753.X

Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07753.X

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07753.X

Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07753.X

Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07753.X

Attenuated free cortisol response to psychosocial stress in children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07753.X

10.1111/J.1365-2133.2007.07753.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018